iiinova — where your digital self keeps evolving

laurenmerzmd.bsky.social

@laurenmerzmd.bsky.social

181 followers 203 following 2 posts

Heme fellow at Dana-Farber/MGH/BWH🩸| Women’s Health and Health Equity research focused 🙎‍♀️| Ask me about the Duffy null phenotype 🧬 | Proud University of Michigan alum 〽️ | dog mom 🐕 #Hemesky #Medsky

Posts Replies Media

Reposted by @laurenmerzmd.bsky.social

Dana-Farber Cancer Institute @danafarber.bsky.social · 11/12/2024

Join @laurenmerzmd.bsky.social at 5 PM PST on @ash-hematology.bsky.social’s virtual platform during the #ASH24 poster walk highlighting her work, Assessing the Contribution of Duffy Null Phenotype to Disparities in Eligibility Criteria for Clinical Trials for Newly-Diagnosed Colorectal Cancer.

052

laurenmerzmd.bsky.social @laurenmerzmd.bsky.social · 07/12/2024

Come talk with me today at 1:15 about universal Duffy testing and how we optimally use the new Duffy null specific ANC reference intervals! #ASH24

030

Reposted by @laurenmerzmd.bsky.social

Heme Queen @heme-queen.bsky.social · 25/11/2024

If we ignore Duffy-null associated neutrophil counts (DANC), we contribute to major disparities in oncology care and clinical trial enrollment. Whether you’re a clinical trialist or clinician, a must-read from @laurenmerzmd.bsky.social and coauthors #medsky #hemesky 🩸🧪 www.nejm.org/doi/abs/10.1...

nejm.org

The Duffy Null Phenotype — Addressing a Source of Discrimination in Cancer Care | NEJM

Cancer research and care practices that adversely affect people with the Duffy null phenotype are an underrecognized and widespread source of discrimination against people of African or Arab ancestry.

072

laurenmerzmd.bsky.social @laurenmerzmd.bsky.social · 23/11/2024

Many absolute neutrophil count thresholds in cancer care do not account for normal levels in people with the Duffy null phenotype— the majority of whom are Black or Middle Eastern. 👇Check out some strategies we propose to address systemic racism in cancer care! www.nejm.org/doi/full/10....

nejm.org

The Duffy Null Phenotype — Addressing a Source of Discrimination in Cancer Care | NEJM

041